GTF2IRD1 and graft versus host disease: Importantly, our published preclinical research in mice supported the replacement of CY with BEN by demonstrating that PT-BEN was equally effective in preventing early GvHD and protecting against late GvHD, while enabling superior GvL when compared to PT-CY (16).